rs116473422
Variant names:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_033124.5(CCDC65):c.1134G>A(p.Gly378Gly) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000884 in 1,613,126 control chromosomes in the GnomAD database, including 13 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0047 ( 5 hom., cov: 30)
Exomes 𝑓: 0.00048 ( 8 hom. )
Consequence
CCDC65
NM_033124.5 synonymous
NM_033124.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.0410
Genes affected
CCDC65 (HGNC:29937): (coiled-coil domain containing 65) This gene encodes a sperm tail protein that is highly expressed in adult testis, spermatocytes and spermatids. The protein plays a critical role in the assembly of the nexin-dynein regulatory complex. Mutations in this gene result in primary ciliary dyskinesia. [provided by RefSeq, Nov 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 12-48921037-G-A is Benign according to our data. Variant chr12-48921037-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 474634.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.041 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00472 (719/152312) while in subpopulation AFR AF= 0.0167 (694/41560). AF 95% confidence interval is 0.0157. There are 5 homozygotes in gnomad4. There are 347 alleles in male gnomad4 subpopulation. Median coverage is 30. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 5 AR gene
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CCDC65 | ENST00000320516.5 | c.1134G>A | p.Gly378Gly | synonymous_variant | Exon 7 of 8 | 1 | NM_033124.5 | ENSP00000312706.4 | ||
ENSG00000272822 | ENST00000398092.4 | c.385-17129C>T | intron_variant | Intron 4 of 4 | 3 | ENSP00000438507.1 |
Frequencies
GnomAD3 genomes AF: 0.00471 AC: 717AN: 152194Hom.: 5 Cov.: 30
GnomAD3 genomes
AF:
AC:
717
AN:
152194
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00142 AC: 355AN: 249958Hom.: 5 AF XY: 0.00104 AC XY: 140AN XY: 135124
GnomAD3 exomes
AF:
AC:
355
AN:
249958
Hom.:
AF XY:
AC XY:
140
AN XY:
135124
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000484 AC: 707AN: 1460814Hom.: 8 Cov.: 31 AF XY: 0.000409 AC XY: 297AN XY: 726648
GnomAD4 exome
AF:
AC:
707
AN:
1460814
Hom.:
Cov.:
31
AF XY:
AC XY:
297
AN XY:
726648
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00472 AC: 719AN: 152312Hom.: 5 Cov.: 30 AF XY: 0.00466 AC XY: 347AN XY: 74466
GnomAD4 genome
AF:
AC:
719
AN:
152312
Hom.:
Cov.:
30
AF XY:
AC XY:
347
AN XY:
74466
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
5
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Primary ciliary dyskinesia 27 Benign:2
Apr 25, 2022
Fulgent Genetics, Fulgent Genetics
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Dec 09, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at